Analyst
Burman Capital
Equibles does not estimate personal net worth.
Shubham Agrawal is recorded as Analyst at Burman Capital. Shubham Agrawal has spoken on 1 earnings call across 1 company, most recently for Viyash Scientific Limited on August 12, 2026. The companies whose calls Shubham Agrawal spoke on are classified in the Healthcare sector.
“We talked about 18 to 20% growth this year. Is that including the benefits of the new acquisition, the buy-off for life, or will those be over and above this 18 to 20% growth?”
Burman Capital
Analyst
Transcript header (unverified)
Viyash Scientific Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Viyash Scientific Limited
